- Home
- MDIA vs OPTN Comparison
MDIA vs OPTN Comparison
Compare MDIA & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- OPTN
- Stock Information
- Founded
- MDIA 2019
- OPTN 2010
- Country
- MDIA United States
- OPTN United States
- Employees
- MDIA N/A
- OPTN N/A
- Industry
- MDIA Broadcasting
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- MDIA Consumer Discretionary
- OPTN Health Care
- Exchange
- MDIA Nasdaq
- OPTN Nasdaq
- Market Cap
- MDIA 51.8M
- OPTN 92.8M
- IPO Year
- MDIA N/A
- OPTN 2017
- Fundamental
- Price
- MDIA $0.92
- OPTN $9.39
- Analyst Decision
- MDIA
- OPTN Hold
- Analyst Count
- MDIA 0
- OPTN 3
- Target Price
- MDIA N/A
- OPTN $9.00
- AVG Volume (30 Days)
- MDIA 35.6K
- OPTN 41.7K
- Earning Date
- MDIA 05-19-2025
- OPTN 05-20-2025
- Dividend Yield
- MDIA N/A
- OPTN N/A
- EPS Growth
- MDIA N/A
- OPTN N/A
- EPS
- MDIA N/A
- OPTN N/A
- Revenue
- MDIA $95,571,000.00
- OPTN $78,226,000.00
- Revenue This Year
- MDIA N/A
- OPTN $30.49
- Revenue Next Year
- MDIA N/A
- OPTN $13.51
- P/E Ratio
- MDIA N/A
- OPTN N/A
- Revenue Growth
- MDIA 195.05
- OPTN 10.20
- 52 Week Low
- MDIA $0.92
- OPTN $4.82
- 52 Week High
- MDIA $5.73
- OPTN $20.03
- Technical
- Relative Strength Index (RSI)
- MDIA 39.35
- OPTN 76.15
- Support Level
- MDIA $0.79
- OPTN $9.14
- Resistance Level
- MDIA $1.00
- OPTN $9.45
- Average True Range (ATR)
- MDIA 0.09
- OPTN 0.08
- MACD
- MDIA -0.02
- OPTN -0.07
- Stochastic Oscillator
- MDIA 31.99
- OPTN 80.71
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.